Study: Women more sensitive to metal joint replacement implants than men

Among joint replacement patients with unexplained pain after surgery, women are more likely than men to test positive for sensitivity to metal used in joint implants, according to a study published in The Journal of Bone & Joint Surgery.

Advertisement

For the study, researchers examined data on 2,613 patients who underwent joint replacement procedures with metal-containing implants and were subsequently evaluated for unexplained postoperative joint pain. Approximately 60 percent of the patients were women.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

On a 10-point scale, women had an average pain score of 6.8, as compared to the average pain score for men, which was 6.1. The patients all underwent a blood test to evaluate sensitization to metals.

Around 49 percent of women tested positive for metal sensitization, as compared to 38 percent of men. Additionally, women tended to have a higher severity of metal sensitivity among those patients who tested positive.

“This supports both our hypothesis and previous reports that females may have a higher risk of adverse responses to implant metals,” study authors wrote.

More articles on healthcare quality:
Building your contingency resources: designing an enterprise resource pool
Bon Secours St. Mary’s undergoes deep clean after 6 bacterial infections
Dr. Peter Pronovost: This unnecessary regulation doesn’t benefit patients and costs $500M each year

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.